title: Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.
authors.forename: Neil
authors.initials: N
authors.lastname: Mo
authors.forename: Senthil
authors.initials: S
authors.lastname: Muthu
authors.forename: Margaret
authors.initials: M
authors.lastname: O'Sullivan
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003424:Crohn Disease / Q000150:complications; D004359:Drug Therapy, Combination; D005123:Eye / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced* / Q000209:etiology / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use*; D008875:Middle Aged; D012307:Risk Factors; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate